Cargando…
In vitro metabolic profile and drug‐drug interaction assessment of secnidazole, a high‐dose 5‐nitroimidazole antibiotic for the treatment of bacterial vaginosis
A single‐dose oral granule formulation of secnidazole 2 g (SOLOSEC(™)) has been approved in the US as a treatment for bacterial vaginosis. Available data on the likelihood of in vitro drug‐drug and alcohol‐drug interactions are limited. Secnidazole was incubated with cultured human hepatocytes over...
Autores principales: | Pentikis, Helen S., Adetoro, Nikki, Kaufman, Gregory |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7416039/ https://www.ncbi.nlm.nih.gov/pubmed/32776491 http://dx.doi.org/10.1002/prp2.634 |
Ejemplares similares
-
An Integrated Efficacy and Safety Analysis of Single-Dose Secnidazole 2 g in the Treatment of Bacterial Vaginosis
por: Pentikis, Helen, et al.
Publicado: (2020) -
Thorough QT/QTc Evaluation of the Cardiac Safety of Secnidazole at Therapeutic and Supratherapeutic Doses in Healthy Individuals
por: Darpo, Borje, et al.
Publicado: (2017) -
Two Phase 1, Open‐Label, Single‐Dose, Randomized, Crossover Studies to Assess the Pharmacokinetics, Safety, and Tolerability of Orally Administered Granules of Secnidazole (2 g) in Healthy Female Volunteers Under Different Administration Conditions
por: Pentikis, Helen S., et al.
Publicado: (2017) -
Secnidazole for treatment of bacterial vaginosis: a systematic review
por: Abd El Aziz, Mohamed A., et al.
Publicado: (2019) -
A comparative study of oral single dose of metronidazole, tinidazole, secnidazole and ornidazole in bacterial vaginosis
por: Thulkar, Jyoti, et al.
Publicado: (2012)